Ticker
TRDACompany Name
ENTRADA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -123.87M | -155.85% | $ 79.48M |
3/31/2025 | $ -54.55M | -31.67% | $ 172.22M |
12/31/2024 | $ -41.56M | -19.72% | $ 210.78M |
9/30/2024 | $ -13.96M | -6.49% | $ 215.23M |
6/30/2024 | $ -14.19M | -5.93% | $ 239.4M |
3/31/2024 | $ -89.11M | -54.71% | $ 162.87M |
12/31/2023 | $ 139.8M | 108.36% | $ 129.01M |
9/30/2023 | $ 116.51M | 133.67% | $ 87.17M |
6/30/2023 | $ 113.52M | 261.39% | $ 43.43M |
3/31/2023 | $ 130.6M | 517.04% | $ 25.26M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for ENTRADA THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -25.57M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |